-
,for, Item ID-
- #1235813
- Providers like you icon 21
- Visby Medical #PS-400380
Respiratory Test Kit Visby Medical™ COVID-19 / Influenza A + B 20 Tests CLIA Waived
TEST, RESPIRATORY HEALTH VISBYCOVID FLU A/B (20/CS) D/S
Features
- The Visby Medical Respiratory Health Test is authorized for Emergency Use by FDA under an EUA for use by Authorized Labs: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
- Visby Medical Respiratory Health Test is a single-use (disposable), fully integrated, rapid, automated RT-PCR in vitro diagnostic test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B viral RNA in healthcare provider-collected nasopharyngeal and anterior nasal swab specimens, and healthcare provider-instructed self-collected anterior nasal swab specimens (collected on site) from individuals with signs and symptoms of respiratory tract infection consistent with COVID-19
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests
- More …
Product Details Email
Product Specifications
McKesson # | 1235813 |
---|---|
Manufacturer # | PS-400380 |
Brand | Visby Medical™ |
Manufacturer | Visby Medical |
Country of Origin | United States |
Application | Respiratory Test Kit |
CLIA Classification | CLIA Waived |
CLIA Classified | CLIA Waived |
Contents 1 | (20) Visby Medical Respiratory Health Test Devices, (24) 650 µL Pipettes, (24) Buffer Tubes, (24) Disposable Bags |
Number of Tests | 20 Tests |
Purchase Program Type | Standard Purchase |
Reading Type | Visual Read |
Sample Type | Anterior Nasal / Nasopharyngeal Swab Sample |
Specialty | Molecular |
Technology | Colorimetric |
Test Format | Test Device Format |
Test Kit Type | Rapid |
Test Name | COVID-19 / Influenza A + B |
Test Type | RT-PCR |
Time to Results | 30 Minute Results |
UNSPSC Code | 41116205 |
Volume | 5.9 mL |
Features
- The Visby Medical Respiratory Health Test is authorized for Emergency Use by FDA under an EUA for use by Authorized Labs: https://www.fda.gov/medical-devices/covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
- Visby Medical Respiratory Health Test is a single-use (disposable), fully integrated, rapid, automated RT-PCR in vitro diagnostic test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B viral RNA in healthcare provider-collected nasopharyngeal and anterior nasal swab specimens, and healthcare provider-instructed self-collected anterior nasal swab specimens (collected on site) from individuals with signs and symptoms of respiratory tract infection consistent with COVID-19
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests
- The Visby Medical Respiratory Health Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B nucleic acid, but do not rule out bacterial infection or co-infection with other pathogens not detected by the test
- Negative results for influenza B are presumptive and should be confirmed with an alternative molecular FDA-cleared or authorized assay, if necessary for patient management
- Negative results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection and should not be used as the sole basis for patient management decisions
- True PCR results that detect and differentiate RNA from the viruses that cause flu and COVID-19, in under 30 minutes with lab accuracy in the palm of your hands
More Information
Professionals Also Viewed
-
,for, Item ID-
- #1076728
- Providers like you icon 6,103
- McKesson Brand #181-36025
- Rapid qualitative test that detects Influenza type A and type B antige …
- Color-coded control swab packaging for easy positive/negative identifi …
- Results in under 15 minutes
-
,for, Item ID-
- #951316
- Providers like you icon 5,561
- McKesson Brand #5003
- A rapid test for the qualitative detection of Strep A antigen in throa …
- CLIA waived and easy to use
- Contents: 25 Dipsticks (in sealed pouches), Disposable extraction test …
-
,for, Item ID-
- #951312
- Providers like you icon 4,625
- McKesson Brand #4999
- A rapid test for the qualitative detection of Strep A antigen in throa …
- CLIA waived and easy to use
- Contents: 50 Dipsticks (2 vials of 25), Disposable extraction test tub …
-
,for, Item ID-
- #1127458
- Providers like you icon 470
- McKesson Brand #181-34125
- A rapid test for the qualitative detection of Strep A antigen in throa …
- Easy-to-use flip step eliminates need for pipetting
- Fast, accurate detection of Group A Strep with walk-away convenience